News and Announcements
Universal Biosensors Annual Report 2016
- Published May 12, 2016 4:18PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
May 12th, ASX Announcement
Chairman’s Letter
“Our company is a proud developer of medical diagnostic systems that make a difference to people’s lives around the world every day. Through our efforts, the technology we have developed with our partners is helping people with diabetes who need to manage their blood glucose levels through LifeScan OneTouch® Verio®, one of the world’s most popular blood glucose monitoring devices. And since December 2014, patients managing their use of the blood thinning drug warfin with the Siemens Xprecia Stride™ are using test strips developed and made at our Rowville facility in Melbourne, Australia.
To view the full report please click on the button below.
Company Updates
BlackRock has named the next Economy. What this latest paper means for Private Market Investors.
BlackRock has put a name on something the smart money has been circling for two years. Its digital assets research team calls it the machine-native economy. The thesis fits in one line. AI is machine-native intelligence. Digital assets are machine-native money. Both are built on the same architecture, and they are converging into a single […]
Where’s the beef? Blackstone just answered the AI question.
In 1984, a fast food ad asked a question that became a catchphrase. Where’s the beef? Jon Gray, President of Blackstone, used that line this month in front of global LPs. It is the question every capital allocator is asking about AI. Trillions of dollars are going into chips, data centres and power. That is […]
The Best of Both Worlds: How Omnique Fund is Rewiring Real World Assets via Tokenisation
For decades, the playbook for Australia’s wholesale investors has remained relatively unchanged: pick between the slow-moving, illiquid reliability of tangible assets like property and gold, or chase the frictionless, high-velocity liquidity of public equity and digital markets. But as macroeconomic volatility spikes and a structural housing deficit reshapes private debt demand, sophisticated investors are demanding […]
Backed By Leading Investment Groups and Family Offices
